TrialInternational journal of hematology2024

Efficacy and safety outcomes in Japanese patients with low-risk polycythemia vera treated with ropeginterferon alfa-2b.

Kazuya Shimoda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.